Endocardial catheter ablation

DEVICE2 trials

Sponsors

Meshalkin Research Institute of Pathology of Circulation, St. George's Hospital, London

Conditions

Atrial ArrhythmiaAtrial FibrillationAtrial Fibrillation, PersistentHeart FailureLeft Ventricular (LV) Systolic DysfunctionParoxysmal Atrial FibrillationPersistent Atrial Fibrillation

Phase 2

Thoracoscopic Versus Endocardial Ablation in Patient With Paroxysmal AF After Failed Initial Endocardial Ablation

CompletedNCT01794416

Meshalkin Research Institute of Pathology of CirculationParoxysmal Atrial Fibrillation

Start: 2011-05-31End: 2013-03-31Updated: 2013-03-26

Unknown Phase

Hybrid Ablation of Atrial Fibrillation in Heart Failure

RecruitingNCT05411614

St. George's Hospital, LondonAtrial Arrhythmia, Atrial Fibrillation, Atrial Fibrillation, Persistent +3

Start: 2022-06-25End: 2027-10-31Target: 120Updated: 2025-11-28

Related Papers

Convergent Hybrid Ablation Versus Catheter Ablation in Patients With Persistent Atrial Fibrillation and Heart Failure: HALT AF Study Protocol and Rationale for a Multicenter Randomized Controlled Trial.

2026-05-29